Although markers of insulin resistance (ΔTG/HDL-C ratio, ΔTyG index) as well as liver stiffness and steatosis indices (CAP) showed no significant change after the intervention, plasma FGF21 levels decreased despite stable BMI. The gene discussed is FGF21; the disease is steatosis.